Research is ongoing to improve the accuracy and consistency of Ki-67 staining. Advances in digital pathology and image analysis are making it easier to standardize the assessment of Ki-67 and other markers. Additionally, new biomarkers and molecular techniques are being developed that may complement or even replace Ki-67 in the future. As our understanding of cancer biology evolves, so too will the tools we use to diagnose and treat this complex group of diseases.
